StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total assets by Year

Crinetics Pharmaceuticals — Total assets ($M) ($M)

Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total assets: $1,126M in FY2025, down 21.5% from a year earlier.

Latest, FY2025
1,126
Period ended Dec 31, 2025
Change on a year earlier
-21.5%
1,435 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: SEC Filing ↗

Reported in SEC XBRL (CIK 0001699813 Crinetics Pharmaceuticals).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCrinetics Pharmaceuticals — Total assets ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,126-21.5%SEC Filing ↗
FY2024Dec 31, 20241,435+125.8%SEC Filing ↗
FY2023Dec 31, 2023635+80.4%SEC Filing ↗
FY2022Dec 31, 2022352+0.3%SEC Filing ↗
FY2021Dec 31, 2021351+91.3%SEC Filing ↗
FY2020Dec 31, 2020183+40.7%SEC Filing ↗
FY2019Dec 31, 2019130-23.9%SEC Filing ↗
FY2018Dec 31, 2018171–SEC Filing ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Crinetics Pharmaceuticals — Total assets ($M), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/crinetics-assets

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.